Design and validation of a neutral protein scaffold for the presentation of peptide aptamers

被引:62
作者
Woodman, R
Yeh, JTH
Laurenson, S
Ferrigno, PK
机构
[1] MRC, Hutchison Res Ctr, Canc Cell Unit, Cambridge CB2 2XZ, England
[2] Univ Cambridge, Canc Res UK, Dept Oncol, Hutchison Res Ctr,MRC, Cambridge CB2 2XZ, England
基金
英国医学研究理事会;
关键词
peptide aptamer; scaffold protein; constrained peptide; stefin A;
D O I
10.1016/j.jmb.2005.08.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Pepticle aptamers are peptides constrained and presented by a scaffold protein that are used to study protein function in cells. They are able to disrupt protein-protein interactions and to constitute recognition modules that allow the creation of a molecular toolkit for the intracellular analysis of protein function. The success of peptide aptamer technology is critically dependent on the performance of the scaffold. Here, we describe a rational approach to the design of a new peptide aptamer scaffold. We outline the qualities that an ideal scaffold would need to possess to be broadly useful for in vitro and in vivo studies and apply these criteria to the design of a new scaffold, called STM. Starting from the, small, stable intracellular protease inhibitor stefin A, we have engineered a biologically neutral scaffold that retains the stable conformation of the parent protein. We show that STM is able to present peptides that bind to targets of interest, both in the context of known interactors and in library screens. Molecular tools based on our scaffold are likely to be used in a wide range of studies of biological pathways, and in the validation of drug targets. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1118 / 1133
页数:16
相关论文
共 51 条
[11]   Peptide aptamers targeting the hepatitis B virus core protein:: a new class of molecules with antiviral activity [J].
Butz, K ;
Denk, C ;
Fitscher, B ;
Crnkovic-Mertens, I ;
Ullmann, A ;
Schröder, CH ;
Hoppe-Seyler, F .
ONCOGENE, 2001, 20 (45) :6579-6586
[12]   Differential localization of cysteine protease inhibitors and a target cysteine protease, cathepsin B, by immuno-confocal microscopy [J].
Calkins, CC ;
Sameni, M ;
Koblinski, J ;
Sloane, BF ;
Moin, K .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1998, 46 (06) :745-751
[13]   Transdominant genetic analysis of a growth control pathway [J].
Caponigro, G ;
Abedi, MR ;
Hurlburt, AP ;
Maxfield, A ;
Judd, W ;
Kamb, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (13) :7508-7513
[14]   An artificial cell-cycle inhibitor isolated from a combinatorial Library [J].
Cohen, BA ;
Colas, P ;
Brent, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (24) :14272-14277
[15]   Targeted modification and transportation of cellular proteins [J].
Colas, P ;
Cohen, B ;
Ferrigno, PK ;
Silver, PA ;
Brent, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (25) :13720-13725
[16]   Genetic selection of peptide aptamers that recognize and inhibit cyclin-dependent kinase 2 [J].
Colas, P ;
Cohen, B ;
Jessen, T ;
Grishina, I ;
McCoy, J ;
Brent, R .
NATURE, 1996, 380 (6574) :548-550
[17]  
Cossins J, 2002, DEVELOPMENT, V129, P2195
[18]   The role of Gly-4 of human cystatin A (Stefin A) in the binding of target proteinases.: Characterization by kinetic and equilibrium methods of the interactions of cystatin a Gly-4 mutants with papain, cathepsin B, and cathepsin L [J].
Estrada, S ;
Nycander, M ;
Hill, NJ ;
Craven, CJ ;
Waltho, JP ;
Björk, I .
BIOCHEMISTRY, 1998, 37 (20) :7551-7560
[19]   Inhibition of mammalian cell proliferation by genetically selected peptide aptamers that functionally antagonize E2F activity [J].
Fabbrizio, E ;
Le Cam, L ;
Polanowska, J ;
Kaczorek, M ;
Lamb, N ;
Brent, R ;
Sardet, C .
ONCOGENE, 1999, 18 (30) :4357-4363
[20]   Mutagenesis by peptide aptamers identifies genetic network members and pathway connections [J].
Geyer, CR ;
Colman-Lerner, A ;
Brent, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (15) :8567-8572